What is CellMEAT?
Based in Gwangju, South Korea, CellMEAT is at the forefront of the alternative protein revolution, specializing in the production of cultured meat, which it brands as "GogiMEAT." The company employs advanced tissue formation techniques from cells to create meat products that offer a sustainable and ethical alternative to traditional livestock farming. This innovative approach positions CellMEAT as a key player in addressing global food security and environmental concerns associated with conventional meat production.
How much funding has CellMEAT raised?
CellMEAT has raised a total of $33.6M across 3 funding rounds:
Other Financing Round
$4.5M
Series A
$8.1M
Series A
$21M
Other Financing Round (2021): $4.5M with participation from Nau Ib Capital, DT Investments, BNK Venture Capital, Ryu Kyung, and PSG Asset Management
Series A (2022): $8.1M led by Strong Ventures, NauIB, BNK VENTURE CAPITAL, and Ryukyung PSG.
Series A (2023): $21M supported by Daewoo Healthcare, Genting Ventures, and NH Venture Investment
Key Investors in CellMEAT
BNK VENTURE CAPITAL
BNK Venture Capital is an investment banking firm based in South Korea, likely focusing on supporting innovative companies within the region's burgeoning tech and biotech sectors.
Strong Ventures
Strong Ventures is an investment firm that appears to back early-stage companies, potentially with a focus on technology and disruptive business models.
Genting Ventures
Genting Ventures is a venture capital arm that likely invests in companies across various sectors, possibly with an interest in food technology and sustainable solutions given their involvement with CellMEAT.
What's next for CellMEAT?
With substantial backing from its recent funding rounds, CellMEAT is poised for significant expansion and further development of its proprietary cultured meat technology. The enterprise-level capital infusion suggests a strategic focus on scaling production capabilities, enhancing research and development for product diversification, and potentially expanding its market reach both domestically and internationally. The company's trajectory indicates a move towards commercialization and establishing a strong foothold in the competitive alternative protein landscape.
See full CellMEAT company page
